All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MV-01LX436 | Anti-ANTXR1 (L2) h(41BB-CD3ζ) CAR, pMMLV | Human | L2 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX437 | Anti-ANTXR1 (1D2) h(41BB-CD3ζ) CAR, pMMLV | Human | 1D2 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX438 | Anti-ANTXR1 (T803) h(41BB-CD3ζ) CAR, pMMLV | Human | T803 | Humanized | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX439 | Anti-ANTXR1 (M830) h(41BB-CD3ζ) CAR, pMMLV | Human | M830 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX440 | Anti-ANTXR1 (L3) h(41BB-CD3ζ) CAR, pMMLV | Human | L3 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX441 | Anti-ANTXR1 (L1) h(41BB-CD3ζ) CAR, pMMLV | Human | L1 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-1122-YF2774 | Anti-ANTXR1 TCR-ABR (scFv-CD3γ, XW-14) CAR Plasmid, pCDCAR1 | Human | XW-14 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF2775 | Anti-ANTXR1 TCR-ABR (scFv-CD3γ, XW-15) CAR Plasmid, pCDCAR1 | Human | XW-15 | Human | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3694 | Anti-ANTXR1 TCR-ABR (scFv-CD3δ, XW-14) CAR Plasmid, pCDCAR1 | Human | XW-14 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF3695 | Anti-ANTXR1 TCR-ABR (scFv-CD3δ, XW-15) CAR Plasmid, pCDCAR1 | Human | XW-15 | Human | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4614 | Anti-ANTXR1 TCR-ABR (scFv-CD3ε, XW-14) CAR Plasmid, pCDCAR1 | Human | XW-14 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF4615 | Anti-ANTXR1 TCR-ABR (scFv-CD3ε, XW-15) CAR Plasmid, pCDCAR1 | Human | XW-15 | Human | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5534 | Anti-ANTXR1 (XW-14) h(CD28-CD3ζ) CAR, pAAV | Human | XW-14 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF5535 | Anti-ANTXR1 (XW-15) h(CD28-CD3ζ) CAR, pAAV | Human | XW-15 | Human | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6454 | Anti-ANTXR1 (XW-14) h(41BB-CD3ζ) CAR, pAAV | Human | XW-14 | Mouse | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6455 | Anti-ANTXR1 (XW-15) h(41BB-CD3ζ) CAR, pAAV | Human | XW-15 | Human | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7374 | Anti-ANTXR1 (XW-14) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-14 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7375 | Anti-ANTXR1 (XW-15) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-15 | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0323-LX3986 | TRAC-ANTXR1 (X3XT188) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT188 | Mouse | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4475 | TRAC-ANTXR1 (X3XT193) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT193 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0823-LX1 | Anti-hANTXR1 (L2) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | L2 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION